Prescribing Aducanumab in the Face of Meager Efficacy and Real Risks

Research output: Contribution to journal › Comment/debate

Access to Document

@article{f4feeea12f674512977583fe75dba16f,

title = "Prescribing Aducanumab in the Face of Meager Efficacy and Real Risks",

author = "Knopman, {David S.} and Perlmutter, {Joel S.}",

year = "2021",

month = sep,

day = "14",

doi = "10.1212/WNL.0000000000012452",

language = "English",

volume = "97",

pages = "545--547",

journal = "Neurology",

issn = "0028-3878",

number = "11",

}

TY - JOUR

T1 - Prescribing Aducanumab in the Face of Meager Efficacy and Real Risks

AU - Knopman, David S.

AU - Perlmutter, Joel S.

PY - 2021/9/14

Y1 - 2021/9/14

UR - http://www.scopus.com/inward/record.url?scp=85114911259&partnerID=8YFLogxK

U2 - 10.1212/WNL.0000000000012452

DO - 10.1212/WNL.0000000000012452

M3 - Comment/debate

C2 - 34233938

AN - SCOPUS:85114911259

VL - 97

SP - 545

EP - 547

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 11

ER -